Thomas P. Stricker, Ph.D.

Affiliations: 
2005 Washington University, Saint Louis, St. Louis, MO 
Area:
Cell Biology
Google:
"Thomas Stricker"

Parents

Sign in to add mentor
Samuel A. Santoro grad student 2005 Washington University
 (The alpha(2) integrin I domain: New lesson and new ligands.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Ludwik KA, Sandusky ZM, Stauffer KM, et al. (2020) RSK2 Maintains Adult Estrogen Homeostasis by Inhibiting ERK1/2-Mediated Degradation of Estrogen Receptor Alpha. Cell Reports. 32: 107931
Lee K, Guerrero-Zotano A, Hanker A, et al. (2020) Abstract GS6-06: A neoadjuvant trial with letrozole identifies PRR11 in the 17q23 amplicon as a mechanism of resistance to endocrine therapy in ER-positive breast cancer Cancer Research. 80
Rahman SJ, Chu S, Zhao S, et al. (2020) Abstract 1137: Deep targeted and whole exome sequencing identifies driver mutations in the airway epithelium of individuals at high risk for lung cancer Cancer Research. 80: 1137-1137
Bergdorf KN, Ferguson DC, Mehrad M, et al. (2019) Papillary thyroid carcinoma behavior: clues in the tumor microenvironment. Endocrine-Related Cancer
Guerrero-Zotano A, Stricker T, Formisano L, et al. (2018) ER+ breast cancers resistant to prolonged neoadjuvant letrozole exhibit an E2F4 transcriptional program sensitive to CDK4/6 inhibitors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Hebron KE, Li EY, Arnold Egloff SA, et al. (2018) Alternative splicing of ALCAM enables tunable regulation of cell-cell adhesion through differential proteolysis. Scientific Reports. 8: 3208
Gonzalez-Ericsson P, Estrada M, Formisano L, et al. (2018) Abstract PD4-07: Genenomic landscape of breast cancers with FGFR1 amplification and FGFR1/CCND1 co-amplification revealed by targeted capture next generation sequencing Cancer Research. 78
Giltnane JM, Hutchinson KE, Stricker TP, et al. (2017) Genomic profiling of ER(+) breast cancers after short-term estrogen suppression reveals alterations associated with endocrine resistance. Science Translational Medicine. 9
Formisano L, Stauffer KM, Young CD, et al. (2017) Association of FGFR1 with ERαmaintains ligand-independent ER transcription and mediates resistance to estrogen deprivation in ER+ breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Hanker AB, Estrada MV, Bianchini G, et al. (2017) Extracellular matrix/integrin signaling promotes resistance to combined inhibition of HER2 and PI3K in HER2+ breast cancer. Cancer Research
See more...